Replies to post #375968 on Elite Pharmaceuticals Inc (ELTP)

[namtae]

Nonsense

There was no PR because in Nasrat's eyes it didn't meet the criteria for a material event.

It clearly met the criteria of a material event, in Elites view, because they filed an 8-k.. the SEC form designed specifically for material event disclosures

A PR has nothing to do with it LOL

Glad I could help

[sharkey1]

Nasrat is swimming with the big dogs now, looks bad, its like, if your selling rolls royces and suddenly you have an old ford for sale,

SABRIL® tablets had annual sales of $180 million in the U.S., according to IQVIA data as of November 2018.

He's got G. AdderaL IR. And XR, worth 2 bill on the market, pluss, next up generic Oxicontin and concerta worth another 4 bill.
Doesn't look good to his peers .